OGT and hepatocellular carcinoma: In HCC, pharmacological inhibition or knockout of USP8 reduces the stability of OGT, thereby suppressing HCC progression and inducing ferroptosis, indicating that targeting USP8 is a potential therapeutic strategy for HCC [68].